Literature DB >> 31096140

Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.

Reza Goudarzi1, Ali Akbari Sari2, Hojjat Zeraati3, Arash Rashidian4, Kazem Mohammad3, Saeed Amini5.   

Abstract

BACKGROUND: The EuroQol 5-dimension (EQ-5D) is a standard instrument that is widely used for measuring health-related quality of life and quality-adjusted life years in economic evaluation of healthcare interventions.
OBJECTIVE: To estimate a preference valuation set for EQ-5D 3-level (3L) health states from the perspective of the general population in the capital of Iran.
METHODS: Eight hundred seventy adults aged ≥18 years were interviewed in Tehran (Iran's capital) from July to November 2013. The participants were selected by a stratified random sampling method and were interviewed face-to-face at their usual residence. Forty-two health states were selected and valued from the 243 states derived from the EQ-5D-3L instrument. Each respondent valued 11 health states using the time trade-off method. Generalized least squares regression with random effect was used to predict values for health states.
RESULTS: The analysis was performed for 846 respondents. The final model yielded the best fit for the time trade-off value at the individual level with an overall R2 of 0.45 and a mean absolute error of 0.214. The mean values for the 42 health states ranged from 0.934 for state 11121 to -0.142 for state 33333.
CONCLUSIONS: This study provided for the first time a value set for calculating quality-adjusted life years from the EQ-5D instrument in Iran. The Iranian EQ-5D-3L value set slightly differs from the value sets of the UK and the United States.
Copyright © 2019 ISPOR--The professional society for health economics and outcomes research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EQ-5D-3L; general population; preference-based measures; time trade-off; value set

Mesh:

Year:  2019        PMID: 31096140     DOI: 10.1016/j.vhri.2019.01.007

Source DB:  PubMed          Journal:  Value Health Reg Issues        ISSN: 2212-1099


  11 in total

1.  Cost-utility analysis of factor VIII diet therapies prepared using blood plasma vs. recombinant technique for patients with hemophilia A.

Authors:  Farhad Lotfi; Hamid Talebianpour; Khosro Keshavarz; Fatemeh Emadi; Mohammad Reza Bordbar; Peivand Bastani
Journal:  Daru       Date:  2020-04-22       Impact factor: 3.117

2.  Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis.

Authors:  Mehdi Rezaee; Mohammad Hossein Morowvat; Maryam Poursadeghfard; Armin Radgoudarzi; Khosro Keshavarz
Journal:  BMC Health Serv Res       Date:  2022-01-28       Impact factor: 2.655

3.  The impact of common chronic conditions on health-related quality of life: a general population survey in Iran using EQ-5D-5L.

Authors:  Ali Akbari Sari; Fereshteh Karimi; Zahra Emrani; Hojjat Zeraati; Alireza Olyaeemanesh; Rajabali Daroudi
Journal:  Cost Eff Resour Alloc       Date:  2021-05-13

4.  Interim value set for the EQ-5D-5L in Iran using the Crosswalk method.

Authors:  Hosein Ameri; Hossein Safari; Mahmood Yousefi; Saeid Bagheri Faradonbeh; Reza Goudarzi; Moslem Soofi
Journal:  Med J Islam Repub Iran       Date:  2020-09-15

5.  Economic evaluation of a national vitamin D supplementation program among Iranian adolescents for the prevention of adulthood type 2 diabetes mellitus.

Authors:  Narges Zandieh; Mohsen Rezaei Hemami; Ali Darvishi; Seyed Mohammad Hasheminejad; Zahra Abdollahi; Maryam Zarei; Ramin Heshmat
Journal:  BMC Complement Med Ther       Date:  2022-01-03

6.  The Study of Cost-Effectiveness of Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Who Developed Ischemic Stroke.

Authors:  Neda Jaberi; Zahra Kavosi; Etrat Hooshmandi; Nasrin Moradi; Khosro Keshavarz; Afshin Borhani-Haghighi
Journal:  Stroke Res Treat       Date:  2021-09-07

7.  Value of willingness to pay for a QALY gained in Iran; a modified chained-approach.

Authors:  Seyedeh-Fariba Jahanbin; Hasan Yusefzadeh; Bahram Nabilou; Cyrus Alinia
Journal:  BMC Health Serv Res       Date:  2021-12-14       Impact factor: 2.655

8.  Rural population's preferences matter: a value set for the EQ-5D-3L health states for China's rural population.

Authors:  Gordon G Liu; Haijing Guan; Xuejing Jin; Han Zhang; Samantha A Vortherms; Hongyan Wu
Journal:  Health Qual Life Outcomes       Date:  2022-01-29       Impact factor: 3.186

9.  EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional study.

Authors:  Sahar Al Shabasy; Maggie Abbassi; Samar Farid
Journal:  BMJ Open       Date:  2021-12-23       Impact factor: 2.692

10.  Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept.

Authors:  Ahmad Gholami; Jassem Azizpoor; Elham Aflaki; Mehdi Rezaee; Khosro Keshavarz
Journal:  Biomed Res Int       Date:  2021-11-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.